Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (ALNY) Q2 2017 Earnings

5MayConfirmed

Q3 2016

Q4 2016

Q1 2017

Q2 2017

-1.37

-1.26

-1.16

-1.05

Details

Expected EPS

-1.26

Actual EPS

-1.25

Surprise EPS

0.01

Surprise Percent

+0.79%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.25 per share for Q2 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.